Food and Drug Administration (FDA) approval process ensures safety and effectiveness for consumers
At Alloy, our medical team carefully evaluates each patients health history, goals, and risk factors to determine if GLP-1 therapy is a safe and effective option
When to Contact Your Clinician or Go to the ER Seek urgent care for chest pain, fainting, severe shortness of breath, or a pulse above 120 to 130 beats per minute that does not respond to rest and hydration
Conclusion Night sweats can be uncomfortable and sometimes alarming
Natural history, phenotypic spectrum, and discriminative features of multisystemic RFC1 disease
If a side effect is troublesome, contact your prescriber before stopping treatment dose changes or supportive care may help.